ATN1

gene product
B37, D12S755E, DRPLA
Dentatorubral pallidoluysian atrophy (DRPLA) is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion from 7-35 copies to 49-93 copies of a trinucleotide repeat (CAG/CAA) within this gene. The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein. [provided by RefSeq, Jul 2016]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
137 antibodies from 25 providers.

Antibody properties

General

Applications

or Cancel
Antibody
Atlas Antibodies
1 antibody
Novus Biologicals
3 antibodies
antibodies-online
39 antibodies
Abgent
1 antibody
Affinity Biosciences
1 antibody
NovoPro Bioscience Inc.
1 antibody
LifeSpan BioSciences, Inc.
40 antibodies
Invitrogen Antibodies
2 antibodies
Abnova Corporation
2 antibodies
R&D Systems
1 antibody
Bioworld Technology, Inc
1 antibody
Creative Biolabs
6 antibodies
Bethyl Laboratories
1 antibody
Proteintech Group
1 antibody
Biorbyt
5 antibodies
Aviva Systems Biology
3 antibodies
OriGene
3 antibodies
Abbkine Scientific Co.Ltd.
1 antibody
GeneTex
1 antibody
Boster Biological Technology
2 antibodies
Creative Diagnostics
2 antibodies
St John's Laboratory
1 antibody
United States Biological
12 antibodies
MyBioSource
3 antibodies
Sigma-Aldrich
4 antibodies